Sort
39,280 grants matching “leukemia”
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$551,802Elizabeth B Lamont · Harvard Medical School · R01 · FY2008 · CA
Targeted therapy of ALL with gene-modified central memory T cells
$551,563Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
ENHANCING NATURAL KILLER CELL MEDIATED TARGETING AND RESPONSES TO MYELOID LEUKEMIAS
$551,362Regents Of The University Of Minnesota · · FY2016 · Department of Defense
Arsenic Trioxide in Primary Curative APL Therapy
$551,295Johns Hopkins University · R01 · FY2004 · CA
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$551,286Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2021 · CA
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$551,286Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2020 · CA
CCR DNA Sequencing MiniCore
$551,172Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$550,845Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Mechanisms and functions of N6-methyladenosine (m6A) in cancer
$550,845Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Mechanisms and functions of N6-methyladenosine (m6A) in cancer
$550,845Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
The Role of PHF6 in HSC self-renewal and myeloid expansion
$550,660Vikram R. Paralkar · University Of Pennsylvania · R01 · FY2022 · HL
HIV Recombination, Double Infection, and Replication Fitness
$550,650Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
RNA Polymerase II as a Therapeutic Target in Acute Myeloid Leukemia (AML) with RAS Signaling Activation
$550,626Catherine Choy Smith · University Of California, San Francisco · R01 · FY2022 · CA
Clinical Trials Exploiting NK Cell Activity
$550,601Daniel J Weisdorf · University Of Minnesota · P01 · FY2019 · CA
Biomarkers for predicting response to Hsp90 therapy
$550,587Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY
$550,574Georgetown University · U10 · FY2005 · CA
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
$550,518Craig Lewis Duvall · Vanderbilt University · R01 · FY2025 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$550,502Kevin M Shannon · University Of California, San Francisco · R01 · FY2016 · CA
PROTEIN SIGNATURES OF LEUKEMIC CELLS
$550,419University Of California San Francisco · R33 · FY2001 · CA
BATF as an inducible regulator of natural killer cell expansion and effector function
$550,375Barbara Lynne Kee · University Of Chicago · R01 · FY2025 · AI
Structural surfaceomics to probe conformation-selective immunotherapy targets
$550,255Arun P. Wiita · University Of California, San Francisco · R01 · FY2024 · CA
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients
$550,245Jennifer Lynne Huberty · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$550,194Wei Li · University Of California-Irvine · R01 · FY2023 · CA
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$550,194Wei Li · University Of California-Irvine · R01 · FY2022 · CA
Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment
$550,174Marilyn J Hockenberry · Duke University · R01 · FY2013 · CA